Written Question·Department of Health and Social Care·UIN 18198

Clozapine: Side Effects

Tabled: 13 July 2026

Answered: 20 July 2026

Question

Lola McEvoy

To ask the Secretary of State for Health and Social Care, whether the Yellow Card adverse drug reaction reference GB-MHRA-MED-202605220730230940-NSQYR (linked to case file CEC 256289) is being actively reviewed by the clinical assessors of the Neurology,

Answer

Preet Kaur Gill

The Medicines and Healthcare products Regulatory Agency (MHRA) confirms that in June 2026, the Neurology, Pain and Psychiatry Expert Advisory Group (NPPEAG) considered an assessment of clozapine drug level monitoring. The NPPEAG provided advice about the ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 18198) →